Abstract
Neuroinflammation has been shown to exacerbate ischemic brain injury, and is considered as a prime target for the development of stroke therapies. Clinacanthus nutans Lindau (C. nutans) is widely used in traditional medicine for treating insect bites, viral infection and cancer, due largely to its anti-oxidative and anti-inflammatory properties. Recently, we reported that an ethanol extract from the leaf of C. nutans could protect the brain against ischemia-triggered neuronal death and infarction. In order to further understand the molecular mechanism(s) for its beneficial effects, two experimental paradigms, namely, in vitro primary cortical neurons subjected to oxygen–glucose deprivation (OGD) and in vivo rat middle cerebral artery (MCA) occlusion, were used to dissect the anti-inflammatory effects of C. nutans extract. Using promoter assays, immunofluorescence staining, and loss-of-function (siRNA) approaches, we demonstrated that transient OGD led to marked induction of IL-1β, IL-6 and TNFα, while pretreatment with C. nutans suppressed production of inflammatory cytokines in primary neurons. C. nutans inhibited IL-1β transcription via preventing NF-κB/p65 nuclear translocation, and siRNA knockdown of either p65 or IL-1β mitigated OGD-mediated neuronal death. Correspondingly, post-ischemic treatment of C. nutans attenuated IκBα degradation and decreased IL-1β, IL-6 and TNFα production in the ischemic brain. Furthermore, IL-1β siRNA post-ischemic treatment reduced cerebral infarct, thus mimicking the beneficial effects of C. nutans. In summary, our findings demonstrated the ability for C. nutans to suppress NF-κB nuclear translocation and inhibit IL-1β transcription in ischemic models. Results further suggest the possibility for using C. nutans to prevent and treat stroke patients.
Similar content being viewed by others
Abbreviations
- b-Gal:
-
β-Galactosidase
- C. nutans :
-
Clinacanthus nutans Lindau
- CN:
-
80% Ethanol extract from the leaf of C. nutans
- CNS:
-
Central nervous system
- DMSO:
-
Dimethyl sulfoxide
- Icv:
-
Intracerebroventricular
- IκBα:
-
NF-κB inhibitor, alpha
- IL-1β:
-
Interleukin-1 beta
- IL-6:
-
Interleukin-6
- MCA:
-
Middle cerebral artery
- NF-κB:
-
Nuclear factor kappa-light-chain-enhancer of activated B cells
- OGD:
-
Oxygen–glucose deprivation
- p65:
-
NF-κB subunit
- PN:
-
Primary cortical neurons
- PPAR-γ:
-
Peroxisome proliferator-activated receptor gamma
- TNFα:
-
Tumor necrosis factor alpha
- TTC:
-
2,3,5-Triphenyltetrazolium chloride
References
Alam, A., Ferdosh, S., Ghafoor, K., Hakim, A., Juraimi, A. S., Khatib, A., et al. (2016). Clinacanthus nutans: A review of the medicinal uses, pharmacology and phytochemistry. Asian Pacific Journal of Tropical Medicine, 9(4), 402–409.
Bis, J. C., Heckbert, S. R., Smith, N. L., Reiner, A. P., Rice, K., Lumley, T., et al. (2008). Variation in inflammation-related genes and risk of incident nonfatal myocardial infarction or ischemic stroke. Atherosclerosis., 198(1), 166–173.
Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001). Role of IL-1α and IL-1β in ischemic brain damage. Journal of Neuroscience, 21(15), 5528–5534.
Brouns, R., & De Deyn, P. P. (2009). The complexity of neurobiological processes in acute ischemic stroke. Clinical Neurology and Neurosurgery, 111(6), 483–495.
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., et al. (2018). Peroxisome proliferator-activated receptor γ (PPAR-γ): A master gatekeeper in CNS injury and repair. Progress in Neurobiology, 163–164, 27–58.
Chawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001). PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine, 7, 48–52.
Chen, Y. C., Wu, J. S., Tsai, H. D., Huang, C. Y., Chen, J. J., Sun, G. Y., et al. (2012a). Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders. Molecular Neurobiology, 46(1), 114–124.
Chen, Y. C., Wu, J. S., Yang, S. T., Huang, C. Y., Chang, C., Sun, G. Y., et al. (2012b). Stroke, angiogenesis and phytochemicals. Frontiers Bioscience, 4, 599–610.
Choudhury, G. R., & Ding, S. (2016). Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiology of Diseases, 85, 234–244.
Clausen, B. H., Wirenfeldt, M., Høgedal, S. S., Frich, L. H., Nielsen, H. H., Schrøder, H. D., et al. (2020). Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke. Acta Neuropathologica Communications, 8(1), 81.
Dyken, M. L. (2010). What lessons have we learned in the past 40 years? Stroke, 41(6), 1073–1075.
Endres, M., Engelhardt, B., Koistinaho, J., Lindvall, O., Meairs, S., Mohr, J. P., et al. (2008). Improving outcome after stroke: Overcoming the translational roadblock. Cerebrovascular Disease, 25(3), 268–278.
Fessler, E. B., Chibane, F. L., Wang, Z., & Chuang, D. M. (2013). Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery. Current Pharmaceutical Design, 19(28), 5105–5120.
Ghizzoni, M., Haisma, H. J., Maarsingh, H., & Dekker, F. J. (2011). Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation. Drug Discovery Today, 16(11–12), 504–511.
Goetz, M. E., Judd, S. E., Hartman, T. J., McClellan, W., Anderson, A., & Vaccarino, V. (2016). Flavanone intake is inversely associated with risk of incident ischemic stroke in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Journal of Nutrition, 146(11), 2233–2243.
Goldberg, M. P., & Choi, D. W. (1993). Combined oxygen and glucose deprivation in cortical cell culture: Calcium-dependent and calcium-independent mechanisms of neuronal injury. Journal of Neuroscience, 13(8), 3510–3524.
Huang, C. Y., Chen, J. J., Wu, J. S., Tsai, H. D., Lin, H., Yan, Y. T., et al. (2015). Novel Link of Anti-apoptotic ATF3 with Pro-apoptotic CTMP in the Ischemic Brain. Molecular Neurobiology, 51(2), 543–557.
Kamarudin, M. N. A., Sarker, M. M. R., Kadir, H. A., & Ming, L. C. (2017). Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review. Journal of Ethnopharmacology, 206, 245–266.
Kao, M. H., & Lin, T. N. (2019). Histone deacetylases in stroke. Chinese Journal of Physiology, 62(3), 95–107.
Khoo, L. W., Audrey Kow, S., Lee, M. T., Tan, C. P., Shaari, K., & Tham, C. L. et al. (2018)A comprehensive review on phytochemistry and pharmacological activities of Clinacanthus nutans (Burm f) Lindau. Evidence-Based Complementary Alternative Medicine 2018:9276260.
Kim, J., Fann, D. Y., Seet, R. C., Jo, D. G., Mattson, M. P., & Arumugam, T. V. (2016). Phytochemicals in ischemic stroke. Neuromolecular Medicine, 18(3), 283–305.
Lambertsen, K. L., Finsen, B., & Clausen, B. H. (2019). Post-stroke inflammation-target or tool for therapy? Acta Neuropathologica, 137(5), 693–714.
Lee, J., Jo, D. G., Park, D., Chung, H. Y., & Mattson, M. P. (2014). Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: Focus on the nervous system. Pharmacological Reviews, 66(3), 815–868.
Liberale, L., Bonetti, N. R., Puspitasari, Y. M., Schwarz, L., Akhmedov, A., Montecucco, F., et al. (2020). Postischemic administration of IL-1α neutralizing antibody reduces brain damage and neurological deficit in experimental stroke. Circulation, 142(2), 187–189.
Lin, H., Lin, T. N., Cheung, W. M., Nian, G. M., Tseng, P. H., Chen, S. F., et al. (2002). Cyclooxygenase-1 (COX-1) and Bicistronic COX-1/Prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation, 105, 1962–1969.
Lin, T. N., He, Y. Y., Wu, G., Khan, M., & Hsu, C. Y. (1993). Effect of brain edema on infarct volume in a focal cerebral ischemia model in the rat. Stroke, 24, 117–121.
Lin, T. N., Wang, C. K., Cheung, W. M., & Hsu, C. Y. (2000). Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. Journal of Cerebral Blood Flow & Metabolism, 20(2), 387–395.
Mai, C. W., Yap, K. S., Kho, M. T., Ismail, N. H., Yusoff, K., Shaari, K., et al. (2016). Mechanisms underlying the anti-inflammatory effects of Clinacanthus nutans Lindau extracts: Inhibition of cytokine production and toll-like receptor-4 activation. Frontiers Pharmacology, 7, 7.
Mehta, S. L., Manhas, N., & Raghubir, R. (2007). Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Research Reviews, 54(1), 34–66.
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., et al. (2006). International Union of Pharmacology LXI. Peroxisome proliferator-activated receptors. Pharmacological Reviews, 58(4), 726–741.
Murakami, M. (2017). Lipoquality control by phospholipase A2 enzymes. Proceedings of the Japan Academy Series B, 93(9), 677–702.
Mutazah, R., Hamid, H. A., Mazila Ramli, A. N., Fasihi Mohd Aluwi, M. F., & Yusoff, M. M. (2020). In vitro cytotoxicity of Clinacanthus nutans fractions on breast cancer cells and molecular docking study of sulphur containing compounds against caspase-3. Food and Chemical Toxicology, 135, 110869.
Ng, G. Y., Lim, Y. A., Sobey, C. G., Dheen, T., Fann, D. Y., & Arumugam, T. V. (2018). Epigenetic regulation of inflammation in stroke. Therapeutic Advances in Neurological Disorders, 11, 1756286418771815.
Nik Abd Rahman, N. M. A., Nurliyana, M. Y., Afiqah, M. N. F. N. N., Osman, M. A., Hamid, M., & Lila, M. A. M. (2019). Antitumor and antioxidant effects of Clinacanthus nutans Lindau in 4 T1 tumor-bearing mice. BMC Complementary and Alternative Medicine, 19(1), 340.
O'Collins, V. E., Macleod, M. R., Donnan, G. A., Horky, L. L., van der Worp, B. H., & Howells, D. W. (2006). 1,026 experimental treatments in acute stroke. Annals of Neurology, 59(3), 467–477.
Schmitz, M. L., & de la Vega, L. (2015). New insights into the role of histone deacetylases as coactivators of inflammatory gene expression. Antioxidants & Redox Signaling, 23(1), 85–98.
Stoll, G., & Nieswandt, B. (2019). Thrombo-inflammation in acute ischaemic stroke—implications for treatment. Nature Reviews Neurology, 15(8), 473–481.
Sun, G. Y., Chuang, D. Y., Zong, Y., Jiang, J., Lee, J. C., Gu, Z., et al. (2014). Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system. Molecular Neurobiology, 50(1), 6–14.
Sun, G. Y., Shelat, P. B., Jensen, M. B., He, Y., Sun, A. Y., & Simonyi, A. (2010). Phospholipases A2 and inflammatory responses in the central nervous system. Neuromolecular Medicine, 12(2), 133–148.
Sun, P., Liu, D. Z., Jickling, G. C., Sharp, F. R., & Yin, K. J. (2018). MicroRNA-based therapeutics in central nervous system injuries. Journal of Cerebral Blood Flow and Metabolism, 38(7), 1125–1148.
Tan, C. S., Ho, C. F., Heng, S. S., Wu, J. S., Tan, B. K., Ng, Y. K., et al. (2016). Clinacanthus nutans extracts modulate epigenetic link to cytosolic phospholipase A2 expression in SH-SY5Y cells and primary neurons. NeuroMolecular Medicine, 18(3), 441–452.
Tsai, H. D., Wu, J. S., Kao, M. H., Chen, J. J., Sun, G. Y., Ong, W. Y., et al. (2016). Clinacanthus nutans protects cortical neurons against hypoxia-induced toxicity by downregulating HDAC1/6. NeuroMolecular Medicine, 18(3), 274–282.
Wang, X., Xue, H., Xu, Q., Zhang, K., Hao, X., Wang, L., et al. (2008). p38 kinase/cytosolic phospholipase A2/cyclooxygenase-2 pathway: A new signaling cascade for lipopolysaccharide-induced interleukin-1beta and interleukin-6 release in differentiated U937 cells. Prostaglandins & Other Lipid Mediators, 86(1–4), 61–67.
Wang, Z. Y., Qin, W., & Yi, F. (2015). Targeting histone deacetylases: Perspectives for epigenetic-based therapy in cardio-cerebrovascular disease. Journal of Geriatric Cardiology, 12(2), 153–164.
Writing Group Members, Mozaffarian, D., & Benjamin, E. J. (2016). Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation, 133(4), e38–360.
Wu, J. S., Cheung, W. M., Tsai, Y. S., Chen, Y. T., Fong, W. H., Tsai, H. D., et al. (2009). Ligand-activated PPAR-γ protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3ε upregulation. Circulation, 119(8), 1124–1134.
Wu, J. S., Kao, M. H., Tsai, H. D., Cheung, W. M., Chen, J. J., Ong, W. Y., et al. (2018). Clinacanthus nutans mitigates neuronal apoptosis and ischemic brain damage through augmenting the C/EBPβ-Driven PPAR-γ transcription. Molecular Neurobiology, 55(7), 5425–5438.
Wu, J. S., Tsai, H. D., Cheung, W. M., Hsu, C. Y., & Lin, T. N. (2016). PPAR-γ ameliorates neuronal apoptosis and ischemic brain injury via suppressing NF-κB−driven p22phox transcription. Molecular Neurobiology, 53(6), 3626–3645.
Wu, J. S., Tsai, H. D., Huang, C. Y., Chen, J. J., & Lin, T. N. (2014). 15-deoxy-∆12,14-PGJ2 via activating peroxisome proliferator-activated receptor-gamma suppresses p22phox transcription to protect brain endothelial cells against hypoxia-induced apoptosis. Molecular Neurobiology, 50(1), 221–238.
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K. (1995). Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke, 26(4), 676–680.
Zakaria, Z. A., Abdul Rahim, M. H., Roosli, R. A. J., Mohd Sani, M. H., Marmaya, N. H., Omar, M. H., et al. (2019). Antinociceptive activity of petroleum ether fraction of Clinacanthus nutans leaves methanolic extract: Roles of nonopioid pain modulatory systems and potassium channels. BioMed Research International, 2019, 6593125.
Zou, L., Zhao, H., Gong, X., Jiang, A., Guan, S., Wang, L., et al. (2015). The association between three promoter polymorphisms of IL-1 and stroke: A meta-analysis. Gene, 567(1), 36–44.
Zulkipli, I. N., Rajabalaya, R., Idris, A., Sulaiman, N. A., & David, S. R. (2017). Clinacanthus nutans: A review on ethnomedicinal uses, chemical constituents and pharmacological properties. Pharmaceutical Biology, 55(1), 1093–1113.
Acknowledgements
This work was supported by grants from the Minister of Science and Technology and Academia Sinica, Taiwan (TNL), and the Ministry of Education, Singapore (WYO; DRH). All authors have read and agreed to the manuscript as written.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kao, MH., Wu, JS., Cheung, WM. et al. Clinacanthus nutans Mitigates Neuronal Death and Reduces Ischemic Brain Injury: Role of NF-κB-driven IL-1β Transcription. Neuromol Med 23, 199–210 (2021). https://doi.org/10.1007/s12017-020-08618-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-020-08618-y